ENTITY
Lupin Ltd

Lupin Ltd (LPC IN)

165
Analysis
Health CareIndia
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
more
10 Sep 2018 19:16

Para IV Winners and Losers - August 2018

This month’s Para IV developments suggest that there is likely to be benefit to Mylan Nv (MYL US) for Minivelle, Teva Pharmaceutical Sp Adr (TEVA...

Logo
278 Views
Share
06 Aug 2018 17:11

Para IV Winners and Losers - July 2018

This month’s Para IV developments suggest that there is likely to be benefit to Par Pharma, Dr. Reddy'S Laboratories (DRRD IN) & Amneal...

Logo
293 Views
Share
10 Jul 2018 15:02

Para IV Winners and Losers - June 2018

This month’s Para IV developments suggest that there is likely to be benefit to Baxter International Inc (BAX US) on Premix Precedex (4mc/ml), Endo...

Logo
340 Views
Share
bearishLupin Ltd
15 Dec 2017 16:47

CC Unlocks The Chambers Of Undisclosed Vitals – Curious Case Of Lupin Limited

The International Financial Reporting Statements (IFRS) – the new accounting standards christened in India as Ind-AS have come into force from...

Logo
837 Views
Share
26 Sep 2017 04:14

Russia Replaces India as Top EM Overweight

In this report, we highlight how Russia has taken over from India as the largest overweight country holding among global emerging market fund...

Logo
369 Views
Share
x